{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:13:25Z","timestamp":1780395205118,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ygyno.2020.02.028","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T02:15:37Z","timestamp":1582942537000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study"],"prefix":"10.1016","volume":"157","author":[{"given":"Chun-Pin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Porucznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-2049","authenticated-orcid":false,"given":"Mia","family":"Hashibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.02.028_bb0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12885-018-4313-x","article-title":"Gynecologic cancer survivor preferences for long-term surveillance","volume":"18","author":"Schlumbrecht","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0015","series-title":"Cancer Treatment & Survivorship Facts & Figures 2019\u20132021","author":"American Cancer Society","year":"2019"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0020","first-page":"5","article-title":"The views of ovarian cancer survivors on its cause, prevention, and recurrence","volume":"6","author":"Stewart","year":"2001","journal-title":"Medscape Womens Health"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2015.10.002","article-title":"The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: a systematic review and meta-analysis","volume":"139","author":"Smits","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0030","doi-asserted-by":"crossref","first-page":"E556","DOI":"10.3747\/co.23.3243","article-title":"Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry","volume":"23","author":"Bhugwandass","year":"2016","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11764-016-0525-8","article-title":"Ovarian cancer survivors\u2019 quality of life: a systematic review","volume":"10","author":"Ahmed-Lecheheb","year":"2016","journal-title":"J. Cancer Surviv."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0040","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1002\/ijc.25642","article-title":"Prospective assessment of quality of life in long-term ovarian cancer survivors","volume":"128","author":"Greimel","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1123\/jpah.6.3.339","article-title":"A population-based study of the determinants of physical activity in ovarian cancer survivors","volume":"6","author":"Stevinson","year":"2009","journal-title":"J. Phys. Act. Health"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2007.03.033","article-title":"Associations between physical activity and quality of life in ovarian cancer survivors","volume":"106","author":"Stevinson","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0055","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/IGC.0000000000001044","article-title":"A physiological profile of ovarian cancer survivors to inform tailored exercise interventions and the development of exercise oncology guidelines","volume":"27","author":"Schofield","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ygyno.2013.02.014","article-title":"Prevalence and incidence of comorbidities in elderly women with ovarian cancer","volume":"129","author":"Chia","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ygyno.2011.11.034","article-title":"Patient reported late effects of gynecological cancer treatment","volume":"124","author":"Grover","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bjc.2011.315","article-title":"Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study","volume":"105","author":"Lind","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/IGC.0000000000000950","article-title":"Epidemiology of second primary tumors in women with ovarian cancer","volume":"27","author":"Kanninen","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2017.12.025","article-title":"Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study","volume":"148","author":"Soisson","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2018.08.016","article-title":"Histotype classification of ovarian carcinoma: a comparison of approaches","volume":"151","author":"Peres","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0095","series-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Kurman","year":"2014"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0100","author":"Agency for Healthcare Research and Quality"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/155.2.176","article-title":"Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology","volume":"155","author":"Hernan","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata J."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1536867X1301300115","article-title":"Review of flexible parametric survival analysis using stata: beyond the Cox Model by Patrick Royston and Paul C. Lambert","volume":"13","author":"Orsini","year":"2013","journal-title":"Stata J."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0125","author":"Behavioral Risk Factor Surveillance System"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0130","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers","volume":"37","author":"Clarke","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2020.02.028_bb0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ijgc-00009577-200602001-00072","article-title":"Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer","volume":"16","author":"Ozguroglu","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1525-1438.2000.00072.x","article-title":"Treatment of advanced ovarian carcinoma with carboplatin and paclitaxel in a patient with renal failure","volume":"10","author":"Jeyabalan","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0145","first-page":"403","article-title":"Acute renal failure associated with intraperitoneal cisplatin chemotherapy with systemic thiosulfate protection in ovarian cancer patients","volume":"12","author":"Menczer","year":"1991","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0150","first-page":"459","article-title":"Pelvic floor disorders in women with gynecologic malignancies: a systematic review","volume":"29","author":"Ramaseshan","year":"2018","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0155","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.4103\/0019-5545.161483","article-title":"Postmenopausal syndrome","volume":"57","author":"Dalal","year":"2015","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0160","first-page":"2889","article-title":"Issues of ovarian cancer survivors in the USA: a literature review","volume":"21","author":"Trivers","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ygyno.2020.02.028_bb0165","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/AOG.0000000000000270","article-title":"Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort","volume":"123","author":"Gaudet","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.02.028_bb0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820301621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820301621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:50:01Z","timestamp":1758772201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820301621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0090825820301621"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}